Alejandro Berlin
Alejandro Berlin
Clinician-Scientist, Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto
Verified email at rmp.uhn.ca
TitleCited byYear
Spatial genomic heterogeneity within localized, multifocal prostate cancer
PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ...
Nature genetics 47 (7), 736, 2015
2552015
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ...
The lancet oncology 15 (13), 1521-1532, 2014
1872014
Genomic hallmarks of localized, non-indolent prostate cancer
M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ...
Nature 541 (7637), 359, 2017
1792017
Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer
M Fraser, A Berlin, RG Bristow, T Van der Kwast
Urologic Oncology: Seminars and Original Investigations 33 (2), 85-94, 2015
902015
A prostate cancer “nimbosus”: genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies
MLK Chua, W Lo, M Pintilie, J Murgic, E Lalonde, V Bhandari, ...
European urology 72 (5), 665-674, 2017
592017
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report
DE Spratt, WH Beeler, FY de Moraes, LD Rhines, JJ Gemmete, ...
The Lancet Oncology 18 (12), e720-e730, 2017
372017
An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy
RG Bristow, A Berlin, A Dal Pra
The British journal of radiology 87 (1035), 20130753, 2014
352014
Translating a prognostic DNA genomic classifier into the clinic: retrospective validation in 563 localized prostate tumors
E Lalonde, R Alkallas, MLK Chua, M Fraser, S Haider, A Meng, J Zheng, ...
European urology 72 (1), 22-31, 2017
252017
Mismatch repair gene expression and genetic instability in testicular germ cell tumor
A Velasco, E Riquelme, M Schultz, II Wistuba, L Villarroel, J Pizarro, ...
Cancer biology & therapy 3 (10), 977-982, 2004
242004
Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer
J Murgic, P Chung, A Berlin, A Bayley, P Warde, C Catton, A Simeonov, ...
Brachytherapy 15 (2), 147-155, 2016
222016
NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer
A Berlin, E Lalonde, J Sykes, G Zafarana, KC Chu, VR Ramnarine, ...
Oncotarget 5 (22), 11081, 2014
222014
Challenges and opportunities in primary CNS lymphoma: a systematic review
MN Kerbauy, FY Moraes, BH Lok, J Ma, LN Kerbauy, DE Spratt, ...
Radiotherapy and Oncology 122 (3), 352-361, 2017
192017
Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancer
H Lieng, M Pintilie, A Bayley, A Berlin, R Bristow, P Chung, ...
Radiotherapy and Oncology 122 (1), 93-98, 2017
182017
Phase 2 trial of guideline-based postoperative image guided intensity modulated radiation therapy for prostate cancer: Toxicity, biochemical, and patient-reported health …
A Berlin, E Cho, V Kong, KJ Howell, B Lao, T Craig, A Bayley, P Chung, ...
Practical radiation oncology 5 (5), e473-e482, 2015
152015
Prognostic role of Ki-67 score in localized prostate cancer: a systematic review and meta-analysis
A Berlin, JF Castro-Mesta, L Rodriguez-Romo, D Hernandez-Barajas, ...
Urologic Oncology: Seminars and Original Investigations 35 (8), 499-506, 2017
112017
Prostate cancer screening characteristics in men with BRCA1/2 mutations attending a high-risk prevention clinic
R Walker, A Louis, A Berlin, S Horsburgh, RG Bristow, J Trachtenberg
Canadian Urological Association Journal 8 (11-12), E783, 2014
102014
Prostate magnetic resonance imaging for brachytherapists: Anatomy and technique
AM Venkatesan, RJ Stafford, C Duran, PD Soni, A Berlin, PW McLaughlin
Brachytherapy 16 (4), 679-687, 2017
92017
Prostate magnetic resonance imaging for brachytherapists: Diagnosis, imaging pitfalls, and post-therapy assessment
AM Venkatesan, RJ Stafford, C Duran, PD Soni, A Berlin, PW McLaughlin
Brachytherapy 16 (4), 688-697, 2017
92017
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy
H Raziee, FY Moraes, J Murgic, MLK Chua, M Pintilie, P Chung, ...
Radiotherapy and Oncology 123 (3), 459-465, 2017
72017
ONECUT2 is a driver of neuroendocrine prostate cancer
H Guo, X Ci, M Ahmed, JT Hua, F Soares, D Lin, L Puca, A Vosoughi, ...
Nature communications 10 (1), 278, 2019
62019
The system can't perform the operation now. Try again later.
Articles 1–20